Beryl Drugs Ltd

NSE: BERLDRG · BSE: 524606 · Pharmaceuticals & Biotechnology · 25 announcements

Share price: ₹25.55
Market cap: ₹12.96 Cr
Revenue (annual): ₹18.82 Cr
Net profit (annual): ₹0.42 Cr
P/E (TTM): 20.8×Sector 47.3×
Promoter holding: 27.82%+0.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Board Meeting Outcome 4 Board Meeting Date 4 Annual General Meeting 4 Promoter Buying 3 Financial Results 3 Other Announcement 1 Debt & Borrowing 1 Capacity Expansion 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Apr 2026 17:11 IST BSE

Other Announcement

Beryl Drugs Other Announcement

Beryl Drugs Ltd submitted a certificate claiming exemption from Corporate Governance provisions under Regulation 15(2) of SEBI LODR for the year ended March 31, 2026. The company qualifies for the exemption as its paid-up capital (₹5.07 Crore) and net worth (₹9.50 Crore) remain below the prescribed regulatory thresholds.

Read the filing ↗